SS Innovations International, Inc. (NASDAQ: SSII) has been named the Outstanding Company at the 2026 Surgical Robotics Industry Awards, surpassing finalists including Intuitive Surgical (NASDAQ: ISRG), Johnson & Johnson (NYSE: JNJ), Medtronic (NYSE: MDT), and several other leading firms. The award recognizes a single company that demonstrates excellence in innovation, commercial success, industry leadership, and positive societal impact.
The recognition places SS Innovations at the forefront of the surgical robotics industry, a sector traditionally dominated by established players. The company's flagship product, the SSi Mantra surgical robotic system, along with its SSi Mudra surgical instruments, are designed to make robotic surgery more affordable and accessible globally. These systems support a variety of procedures, including cardiac surgery.
SS Innovations, an American company headquartered in India, plans to expand the global presence of its technologically advanced, user-friendly, and cost-effective surgical robotic solutions. The award underscores the company's potential to disrupt the market and bring robotic surgery to a larger segment of the population.
For more information about SS Innovations and its latest developments, visit the company's newsroom at https://ibn.fm/SSII.
This achievement is significant as it highlights a shift in the surgical robotics landscape, where smaller, innovative companies are challenging established giants. The implications for the industry include increased competition, potential cost reductions, and broader access to robotic surgery technologies.
